Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

FDA Advisory on Nevirapine

February 28, 2005

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

On January 19, 2005, the FDA issued a public health advisory recommending against starting ongoing nevirapine treatment in women with a CD4 count greater than 250, unless benefits clearly outweigh risks. Both men and women (but especially women) with a high CD4 count are at greater risk of liver toxicity from nevirapine than those with more advanced HIV disease. This warning is not new; the manufacturer Boehringer Ingelheim warned about the same liver risk in February 2004. The new advisory reflects recent changes to the package insert, and also provides an excellent short summary on risks and benefits of nevirapine. The FDA noted that "serious and fatal liver toxicity has not been reported after single doses of nevirapine" (used to prevent mother-to-infant HIV transmission during childbirth) -- and that "symptomatic liver toxicity has not been reported in HIV-infected children, and nevirapine is available in a liquid formulation while many other antiretrovirals are not."

The FDA advisory is at www.fda.gov/cder/drug/advisory/Nevirapine.htm.


ISSN # 1052-4207

Copyright 2005 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.

Advertisement

Back to the AIDS Treatment News February 28, 2005 contents page.

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.
 
See Also
More on HIV Medications
More News on Nevirapine (Viramune)
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement